This is an automatically translated article.
Mucosta, whose active ingredient is rebamipide, is a prescription medication that acts as a protective agent for cells lining the gastrointestinal tract. Accordingly, the use of Mucosta is used in the treatment of stomach ulcers and gastritis. The following information is necessary before taking the drug and monitoring during treatment.1. What is Mucosta?
Mucosta is the brand name of the active ingredient rebamipide. This is an amino acid derivative of 2-(1H)-quinolinone, which is used to protect the mucosa, heal peptic ulcers, and treat gastritis. The drug's mechanism of action is by enhancing mucosal defenses, scavenging free radicals and transiently activating genes encoding cyclooxygenase-2.
A series of studies have shown that rebamipide can counteract the harmful effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the lining of the gastrointestinal tract, including the small intestine. However, the ability of the drug to protect against gastric damage caused by naproxen has not been clearly demonstrated.
2. What is the use of Mucosta?
Mucosta or rebamipide has the main ingredient in it and is available in both oral and ophthalmic formulations. The oral form of this medication acts as a mucosal protector and is used to treat ulcers in the stomach and intestines in adult patients. The ophthalmic form of this medication is used to treat dry eyes. In particular, the effect on the gastrointestinal tract plays a key role in the use of Mucosta. Therefore, the indications of rebamipide prescribed for the treatment of peptic ulcers, peptic ulcers and gastric disorders include the following:
Indicated in cases of bleeding, erosion, Redness and edema, or all signs of gastric mucosal damage in general, occur in the setting of acute gastritis and also in acute exacerbations of chronic gastritis. Indicated as an effective and safe drug in the treatment of recurrent oral mucosal ulcers in Behcet's disease.
![Mucosta có tác dụng trong điều trị viêm loét niêm mạc miệng](/static/uploads/small_20200324_141915_849182_1_35372_vpai_max_1800x1800_jpg_79aadfd7fd.jpg)
Mucosta có tác dụng trong điều trị viêm loét niêm mạc miệng
3. What is the dose of Mucosta?
Dosage Mucosta is available as a tablet with the active ingredient, rebamipide, 100 mg can be prescribed in adults as 1 tablet each time and taken three times a day.
The time to take the drug that has been shown to be most effective is in the morning, afternoon and evening before going to bed.
4. What are the precautions when taking Mucosta?
Before starting the drug, the treating doctor or clinical pharmacist should inform the patient of the following precautions when taking Mucosta:
Because elderly patients may have physiological changes More sensitive to this drug and more prone to gastrointestinal disturbances than younger patients, special care should be taken when administering the drug to these subjects. Use in women who are pregnant or may become pregnant only if the expected benefit of treatment is thought to outweigh any potential risks associated with pregnancy. Breast-feeding should be avoided during the indicated period of use. Drugs that may interact with celecoxib or diclofenac
![Tránh cho con bú trong quá trình được chỉ định sử dụng thuốc Mucosta](/static/uploads/medium_20200221_163610_475915_phu_nu_cho_con_bu_g_max_1800x1800_jpeg_71a91012ec.jpg)
Tránh cho con bú trong quá trình được chỉ định sử dụng thuốc Mucosta
5. What are the side effects of taking Mucosta?
Side effects when taking Mucosta are as follows:
Itching and skin rash Nausea and vomiting Dizziness Loss of appetite Bitter or unusual taste Dry mouth Blurry vision Eye irritation Eye discharge Constipation Bloating Diarrhea Epigastric pain Heat, belching Cold sweat Feeling short of breath
6. What are the monitoring measures during treatment with Mucosta?
Stop taking the drug and proceed to bring the patient immediately to the nearest emergency department if allergic reactions or suspicious signs such as difficulty breathing or swallowing, chest tightness, swelling, skin rash and hives.
![Người bệnh có thể xuất hiện nổi mề đay sau khi sử dụng thuốc Mucosta](/static/uploads/small_20190903_132630_941172_di_ung_thoi_tiet_ma_max_1800x1800_jpg_f7c1175958.jpg)
Người bệnh có thể xuất hiện nổi mề đay sau khi sử dụng thuốc Mucosta
Patients should be closely monitored for leukopenia, thrombocytopenia and liver dysfunction during treatment with Mucosta.
In summary, Mucosta or rebamipide is an anti-gastric and anti-ulcer drug used to protect the mucosa, heal gastric ulcers, small intestine and treat gastritis. However, the drug can cause unwanted side effects. Therefore, the use of the drug should be prescribed and strictly followed the instructions on the dose to achieve the best effect and safety for the patient.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
References: practo.com, medindia.net